John Driscoll

John is the CEO of CareCentrix. Prior to CareCentrix, John served as President at Castlight Health and as Group President for new markets at Medco, a $70 billion pharmacy benefit manager). During his years at Medco, John was part of the senior management team that spun Medco out of Merck, building an enterprise that was named as the most admired company in healthcare services by Fortune.

Previously, John founded and chaired the Surescripts ePrescribing Network. John also served as an Advisor to Oak Investment Partners and was a member of the executive team at Oxford Health Plans, serving as Corporate Vice President for government programs. John was selected by the White House for its Entrepreneurs in Residence program in 2011 to advise the FDA on new paths for innovation.